Brief: Organogenesis Q1 Adjusted EBITDA USD 3.8 Mln
10/05/2023 21:10
May 10 (Reuters) - Organogenesis Q1 revenue USD 107.6 million. * Q1 net income USD -3 million * Q1 adjusted net income USD -700 thousand * Q1 operating income USD -4 million * Q1 adjusted EBITDA USD 3.8 million * Outlook FY net income USD 3-11 million * Outlook FY EBITDA USD 28-39 million * Outlook FY adjusted net income USD 8-16 million * Outlook FY adjusted EBITDA USD 38-49 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers